These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 3956771

  • 21. Selective transsphenoidal adenomectomy in women with galactorrhea-amenorrhea.
    Post KD, Biller BJ, Adelman LS, Molitch ME, Wolpert SM, Reichlin S.
    JAMA; 1979 Jul 13; 242(2):158-62. PubMed ID: 448889
    [Abstract] [Full Text] [Related]

  • 22. Luteinizing hormone- and alpha-subunit-secreting pituitary tumor: positive feedback of estrogen.
    Peterson RE, Kourides IA, Horwith M, Vaughan ED, Saxena BB, Fraser RA.
    J Clin Endocrinol Metab; 1981 Apr 13; 52(4):692-8. PubMed ID: 6782117
    [No Abstract] [Full Text] [Related]

  • 23. Serum prolactin and growth hormone response to thyrotropin-releasing hormone in patients with pituitary adenomas.
    Chang CC, Chen FW, Hsieh HC.
    Taiwan Yi Xue Hui Za Zhi; 1989 May 13; 88(5):443-9. PubMed ID: 2507734
    [Abstract] [Full Text] [Related]

  • 24. Surgical treatment of prolactin-secreting pituitary adenomas: early results and long-term outcome.
    Losa M, Mortini P, Barzaghi R, Gioia L, Giovanelli M.
    J Clin Endocrinol Metab; 2002 Jul 13; 87(7):3180-6. PubMed ID: 12107221
    [Abstract] [Full Text] [Related]

  • 25. Studies on pituitary function in patients with B-cell adenoma.
    Zaccaria M, Giordano G, Vettor R, Ragazzi E, Boscaro M, Federspil G, Scandellari C.
    Horm Metab Res; 1983 Nov 13; 15(11):562-3. PubMed ID: 6317536
    [No Abstract] [Full Text] [Related]

  • 26. Recovery from paradoxical growth hormone responses in acromegaly after transphenoidal selective adenomectomy.
    Hoyte KM, Martin JB.
    J Clin Endocrinol Metab; 1975 Oct 13; 41(4):656-9. PubMed ID: 809457
    [Abstract] [Full Text] [Related]

  • 27. Pituitary-adrenocortical response to metoclopramide in patients with acromegaly and prolactinoma: a clinical evaluation of catecholamine-mediated adrenocorticotropin secretion.
    Nishida S, Matsuki M, Adachi N, Horino M, Yoneda M, Endoh M, Oyama H, Kikuoka M, Otsuka R, Ishii R.
    J Clin Endocrinol Metab; 1987 May 13; 64(5):995-1001. PubMed ID: 3031125
    [Abstract] [Full Text] [Related]

  • 28. Prolactin response to perphenazine. A sensitive and specific test for pituitary tumor in hyperprolactinemic women.
    Mattox JH, Fortunato SJ.
    J Reprod Med; 1986 Dec 13; 31(12):1098-101. PubMed ID: 3795197
    [Abstract] [Full Text] [Related]

  • 29. Prolactin gene expression in human growth hormone-secreting pituitary adenomas.
    Nagaya T, Seo H, Kuwayama A, Sakurai T, Tsukamoto N, Sugita K, Matsui N.
    J Neurosurg; 1990 Jun 13; 72(6):879-82. PubMed ID: 2338572
    [Abstract] [Full Text] [Related]

  • 30. [Characteristics of growth hormone secretion in the hyperprolactinemia syndrome].
    Gorgoshidze BV, Sabakhtarashvili MA, Veĭnberg EG, Kurashvili RB, Dundua MG.
    Probl Endokrinol (Mosk); 1983 Jun 13; 29(1):34-9. PubMed ID: 6682223
    [Abstract] [Full Text] [Related]

  • 31. Effects of naloxone on prolactin, growth hormone and cortisol response to insulin hypoglycemia in obese subjects.
    Papalia D, Lunetta M, Di Mauro M.
    J Endocrinol Invest; 1989 Dec 13; 12(11):777-82. PubMed ID: 2693516
    [Abstract] [Full Text] [Related]

  • 32. Nomifensine, TRH and insulin-induced hypoglycemia tests in the diagnosis of prolactinomas.
    Iannotta F, Fachinetti P, Fachinetti A, Pinotti G, Usellini L.
    J Endocrinol Invest; 1983 Oct 13; 6(5):353-8. PubMed ID: 6420458
    [Abstract] [Full Text] [Related]

  • 33. Absence of suppressive effect of somatostatin on prolactin levels in patients with hyperprolactinemia.
    Bronstein MD, Knoepfelmacher M, Liberman B, Marino R, Germek OA, Schally AV.
    Horm Metab Res; 1987 Jun 13; 19(6):271-4. PubMed ID: 2887502
    [Abstract] [Full Text] [Related]

  • 34. Recovery of pituitary function following surgical removal of large nonfunctioning pituitary adenomas.
    Arafah BM, Brodkey JS, Manni A, Velasco ME, Kaufman B, Pearson OH.
    Clin Endocrinol (Oxf); 1982 Sep 13; 17(3):213-22. PubMed ID: 7165966
    [No Abstract] [Full Text] [Related]

  • 35. Serial plasma growth hormone concentration during selective removal of pituitary tumors in acromegaly.
    Allen JP, Cook DM, Greer MA, Paxton H, Castro A.
    J Neurosurg; 1974 Jul 13; 41(1):38-43. PubMed ID: 4366356
    [No Abstract] [Full Text] [Related]

  • 36. [Transsphenoidal surgery in hypersecreting pituitary tumors: endocrine follow-up (author's transl)].
    Guibout M, Jaquet P, Lissitzky JC, Grisoli F, Vincentelli F.
    Ann Endocrinol (Paris); 1978 Jul 13; 39(2):95-106. PubMed ID: 687397
    [Abstract] [Full Text] [Related]

  • 37. Transsphenoidal microsurgical treatment of prolactin-producing pituitary adenomas. Results in 100 patients.
    Randall RV, Laws ER, Abboud CF, Ebersold MJ, Kao PC, Scheithauer BW.
    Mayo Clin Proc; 1983 Feb 13; 58(2):108-21. PubMed ID: 6681646
    [Abstract] [Full Text] [Related]

  • 38. Defective dopaminergic regulation of prolactin secretion in patients with hyperprolactinemia.
    Serri O, Beauregard H, Somma M, Comtois R, Jilwan N, Hardy J.
    Clin Invest Med; 1988 Dec 13; 11(6):387-91. PubMed ID: 3229037
    [Abstract] [Full Text] [Related]

  • 39. Masked hyperprolactinemia: tumor-derived factors inhibiting prolactin secretion caused by pituitary-stalk damage.
    Kinoshita Y, Hama S, Tominaga A, Arita K, Sugiyama K, Sakoguchi T, Usui S, Kurisu K.
    J Clin Neurosci; 2011 Dec 13; 18(12):1651-5. PubMed ID: 22015098
    [Abstract] [Full Text] [Related]

  • 40. [Prolactinomas and "idiopathic" hyperprolactinemia. Case series].
    Volpe A, Grasso A, Oliva A, Bramanti P, Leggiadro N, Musolino R, Meduri M.
    Riv Neurol; 1980 Dec 13; 50(5):350-61. PubMed ID: 6781058
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.